Evelo Biosciences Inc reports results for the quarter ended in March - Earnings Summary

Evelo Biosciences

12/05/2022 12:54

* Evelo Biosciences Inc  EVLO.OQ  reported a quarterly
adjusted
loss of 56 cents​​ per share for the quarter ended in March. The
mean expectation of six analysts for the quarter was for a loss
of 58 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Evelo Biosciences Inc's reported EPS for the quarter was a
loss
of 56 cents​.
    * The mean earnings estimate of analysts had risen by
about 4.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Evelo Biosciences Inc shares had fallen by 38.9% this
quarter and lost 65.9% so far this year.
    * The company reported a quarterly loss of $29.86 million.
    * Wall Street's median 12-month price target for Evelo
Biosciences
Inc is $18.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 12 at 11:54 a.m.  ​All
figures in US dollars unless otherwise stated